IBDEI0ML ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10153,0)
 ;;=E86.0^^39^429^1
 ;;^UTILITY(U,$J,358.3,10153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10153,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,10153,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,10153,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,10154,0)
 ;;=E86.1^^39^429^4
 ;;^UTILITY(U,$J,358.3,10154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10154,1,3,0)
 ;;=3^Hypovolemia
 ;;^UTILITY(U,$J,358.3,10154,1,4,0)
 ;;=4^E86.1
 ;;^UTILITY(U,$J,358.3,10154,2)
 ;;=^332744
 ;;^UTILITY(U,$J,358.3,10155,0)
 ;;=E86.9^^39^429^5
 ;;^UTILITY(U,$J,358.3,10155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10155,1,3,0)
 ;;=3^Volume Depletion,Unspec
 ;;^UTILITY(U,$J,358.3,10155,1,4,0)
 ;;=4^E86.9
 ;;^UTILITY(U,$J,358.3,10155,2)
 ;;=^332840
 ;;^UTILITY(U,$J,358.3,10156,0)
 ;;=E87.0^^39^429^2
 ;;^UTILITY(U,$J,358.3,10156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10156,1,3,0)
 ;;=3^Hyperosmolality & Hpernatremia
 ;;^UTILITY(U,$J,358.3,10156,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,10156,2)
 ;;=^5003018
 ;;^UTILITY(U,$J,358.3,10157,0)
 ;;=E87.1^^39^429^3
 ;;^UTILITY(U,$J,358.3,10157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10157,1,3,0)
 ;;=3^Hypo-osmolality & Hyponatremia
 ;;^UTILITY(U,$J,358.3,10157,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,10157,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,10158,0)
 ;;=E10.10^^39^430^18
 ;;^UTILITY(U,$J,358.3,10158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10158,1,3,0)
 ;;=3^DM Type 1 w/ Ketoacidosis w/o Coma
 ;;^UTILITY(U,$J,358.3,10158,1,4,0)
 ;;=4^E10.10
 ;;^UTILITY(U,$J,358.3,10158,2)
 ;;=^5002587
 ;;^UTILITY(U,$J,358.3,10159,0)
 ;;=E10.11^^39^430^17
 ;;^UTILITY(U,$J,358.3,10159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10159,1,3,0)
 ;;=3^DM Type 1 w/ Ketoacidosis w/ Coma
 ;;^UTILITY(U,$J,358.3,10159,1,4,0)
 ;;=4^E10.11
 ;;^UTILITY(U,$J,358.3,10159,2)
 ;;=^5002588
 ;;^UTILITY(U,$J,358.3,10160,0)
 ;;=E10.21^^39^430^8
 ;;^UTILITY(U,$J,358.3,10160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10160,1,3,0)
 ;;=3^DM Type 1 w/ Diab Nephropathy
 ;;^UTILITY(U,$J,358.3,10160,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,10160,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,10161,0)
 ;;=E10.22^^39^430^3
 ;;^UTILITY(U,$J,358.3,10161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10161,1,3,0)
 ;;=3^DM Type 1 w/ Diab CKD
 ;;^UTILITY(U,$J,358.3,10161,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,10161,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,10162,0)
 ;;=E10.29^^39^430^24
 ;;^UTILITY(U,$J,358.3,10162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10162,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,10162,1,4,0)
 ;;=4^E10.29
 ;;^UTILITY(U,$J,358.3,10162,2)
 ;;=^5002591
 ;;^UTILITY(U,$J,358.3,10163,0)
 ;;=E10.311^^39^430^12
 ;;^UTILITY(U,$J,358.3,10163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10163,1,3,0)
 ;;=3^DM Type 1 w/ Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10163,1,4,0)
 ;;=4^E10.311
 ;;^UTILITY(U,$J,358.3,10163,2)
 ;;=^5002592
 ;;^UTILITY(U,$J,358.3,10164,0)
 ;;=E10.319^^39^430^13
 ;;^UTILITY(U,$J,358.3,10164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10164,1,3,0)
 ;;=3^DM Type 1 w/ Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10164,1,4,0)
 ;;=4^E10.319
 ;;^UTILITY(U,$J,358.3,10164,2)
 ;;=^5002593
 ;;^UTILITY(U,$J,358.3,10165,0)
 ;;=E10.3211^^39^430^19
 ;;^UTILITY(U,$J,358.3,10165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10165,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
